Skip to main content
Clinical Trials/ITMCTR2000002898
ITMCTR2000002898RecruitingPhase 4

Re-evaluation of Zhui-Feng Tou-Gu capsule in the treatment of Osteoarthritis after marketing

Temporarily not sure0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational study

Eligibility Criteria

Ages
18 to 80 (—)
Sex
All

Inclusion Criteria

  • (1) Aged 18-80 years;
  • (2) meet the diagnostic criteria of osteoarthritis.

Exclusion Criteria

  • (1) complications affecting joints, such as psoriasis, syphilitic neuropathy, Brown yellows, acute trauma, etc.;
  • (2) bleeding tendency, gastrointestinal bleeding or other chronic bleeding disorders within the last month;
  • (3) combined with tumor, bone tuberculosis, fracture and other cervical spine lesions or injuries;
  • (4) pregnant, breast-feeding women;
  • (5) allergic constitution or allergic to known ingredients of this drug;
  • (6) complicated with serious diseases of heart, lung, liver, kidney, hematopoiesis and immune system.

Investigators

Sponsor
Temporarily not sure

Similar Trials